Price
$3.03
Decreased by -3.35%
Dollar volume (20D)
200.79 K
ADR%
9.81
Earnings report date
May 8, 2024
Shares float
12.71 M
Shares short
757.20 K [5.96%]
Shares outstanding
26.30 M
Market cap
162.02 M
Beta
0.16
Price/earnings
N/A
20D range
3.00 4.20
50D range
3.00 6.90
200D range
1.82 8.75

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States.

The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies.

Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions.

The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity.

Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 8, 24 0.00
Increased by +100.00%
-0.42
Increased by +100.00%
Mar 20, 24 0.00
Increased by +100.00%
-0.31
Increased by +100.00%
Nov 8, 23 -0.36
Decreased by -9.09%
-0.37
Increased by +2.70%
Aug 11, 23 -0.37
Decreased by -19.35%
-0.40
Increased by +7.50%
May 10, 23 -0.33
Decreased by -13.79%
-0.41
Increased by +19.51%
Mar 22, 23 -0.35
Decreased by -29.63%
-0.35
Nov 10, 22 -0.33
Decreased by -175.00%
-0.47
Increased by +29.79%
Aug 10, 22 -0.31
Decreased by -158.33%
-0.58
Increased by +46.55%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 23 0.00
Decreased by N/A%
-9.20 M
Increased by +43.26%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-9.30 M
Increased by +41.73%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-8.37 M
Increased by +39.46%
Decreased by N/A%
Decreased by N/A%
Dec 31, 22 0.00
Increased by +100.00%
-17.34 M
Decreased by -31.16%
Decreased by N/A%
Decreased by N/A%
Sep 30, 22 0.00
Decreased by N/A%
-16.21 M
Decreased by -415.85%
Decreased by N/A%
Decreased by N/A%
Jun 30, 22 0.00
Decreased by -100.00%
-15.97 M
Decreased by -191.08%
Decreased by N/A%
Decreased by N/A%
Mar 31, 22 0.00
Decreased by -100.00%
-13.83 M
Decreased by -147.02%
Decreased by N/A%
Decreased by N/A%
Dec 31, 21 -2.72 M
Decreased by -1.39 K%
-13.22 M
Increased by +20.83%
Increased by +486.68%
Increased by +106.12%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY